Takis and Evvivax developing a 2019-nCoV Coronavirus vaccine
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction
2-3 July 2019 – Evvivax presents data at the University of Copenaghen
27 February – 1 March 2019 – Evvivax is a sponsor of the 1st VITARES Annual Meeting, Rome, Italy
LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines
25-29 October - EVVIVAX to present data at the Veterinary Cancer Society, Portland, Oregon (USA)